CRSP vs HPQ · rev $11.6M vs P/E 8.6, rev $44.52B
Crispr Therapeutics AG (CRSP) versus HP Inc (HPQ) — a side-by-side from cached financials, not a winner call.
Crispr Therapeutics AG (CRSP) is a biotechnology company listed on US.
HP Inc (HPQ) is a computer hardware company listed on NYSE.
Latest reported CRSP revenue for 2026-06-30 was $11.6M. Net income was -$214.1M. CRSP currently screens at market cap $5.42B.
Latest reported HPQ revenue for 2026-07-31 was $44.52B. Net income was $1.66B. Revenue was up 54.3% from 2026-04-30 to 2026-07-31. HPQ currently screens at market cap $21.20B and trailing P/E 8.6.
CRSP currently screens at market cap $5.42B. HPQ currently screens at market cap $21.20B and trailing P/E 8.6.
Not investment advice. Open the CRSP and HPQ stock pages for the full models.
Not investment advice.